Tiny Gem

US Military Admits it is Using AI in Attacks Against Iran

The U.S. military has confirmed that AI systems are actively involved in its ongoing operations against Iran, an admission that has added significant fuel to an international debate that was already running hot. 

Brad Cooper, commander of U.S. Central Command, outlined the role of artificial intelligence systems in a publicly released video. He positioned AI as critical infrastructure for processing the enormous volumes of information that flow through a modern military campaign. 

Cooper was explicit that the technology shapes the conditions in which decisions are made. It compresses analysis that once took many hours into something commanders can act on almost immediately. He also said that human judgment is governing every targeting choice without exception, but those assurances have not settled the argument. 

strike on an educational facility in southern Iran killed more than 170 people, the overwhelming majority of them children. The cumulative toll of the U.S.-Israeli war effort has surpassed 1,300 since operations began in late February, casting a somber light on the swiftly growing AI segment. 

Running alongside the military disclosure is a sharp conflict between the Trump administration and AI company Anthropic. Anthropic had an existing Defense Department arrangement but drew a firm line, refusing to permit applications involving autonomous weapons or systematic civilian surveillance. Washington responded by designating the company a procurement risk and severing its government access. 

Anthropic took the matter to court. A Defense Department spokesperson made clear that military decisions would not be subordinated to the preferences of technology firms answering to no electorate. 

OpenAI moved into that space by securing its own Pentagon agreement, and the reaction from its user base has been immediate and clear. Consumer advocates have challenged whether a company embedded in millions of people’s daily lives should be contracting with active military operations. 

Many argue that safety commitments and battlefield partnerships are fundamentally incompatible. The Anthropic standoff has made that tension impossible to ignore, and OpenAI’s decision to step in where Anthropic drew a line has only sharpened the question. 

Those concerns draw on a pattern that predates the current conflict between the U.S., Israel, and Iran. Independent monitors have catalogued extensive AI-driven targeting during Israeli military operations in Gaza, where more than 72,000 people have been killed since late 2023. What that record illustrates, critics say, is that accountability does not scale alongside automation. The faster and more autonomous the decision pipeline becomes, the harder it is to locate where responsibility sits. Accountability, in that environment, tends to dissolve entirely. 

Beijing has weighed in with language that carries its own strategic subtext. China’s Defense Ministry argued that bringing AI into warfare without enforceable constraints dismantles the accountability structures that international law depends on. 

A ministry spokesperson said handing lethal authority to automated systems sets in motion an escalation that institutions may not be equipped to contain. The spokesperson reached for science fiction to illustrate where that trajectory leads. That point is harder to dismiss now that a major military power has confirmed the practice mid-conflict. 

Other tech companies like D-Wave Quantum Inc. (NYSE: QBTS), focused on developing cutting-edge technology solutions, will be keenly following how the debate over the use of AI in combat operations pans out. 

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Austin, Texas
www.TinyGems.com
512.354.7000 Office
Editor@TinyGems.com

TinyGems is powered by IBN

Alex Pearon

Share
Published by
Alex Pearon

Recent Posts

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight…

8 hours ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands LB 100 Development Through Strategic Academic and Pharma Partnerships

LIXTE recently expanded its ovarian clear cell cancer trial in partnership with MD Anderson and…

3 days ago

Researchers Trace Differing Pediatric Brain Tumors to Common Source

New research has uncovered a shared biological weakness running across three distinct pediatric brain cancers, a finding…

5 days ago

Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy

LIXTE Biotechnology Holdings and the company’s subsidiary, Liora Technologies, both develop products that aim to…

1 week ago

Ongoing Digital Monitoring Could Make Immunotherapy More Accessible

Ongoing digital monitoring could be about to solve one of modern medicine's most frustrating access problems.…

1 week ago

Frontieras North America Inc. Is ‘One to Watch’

Frontieras’ patent portfolio includes protection across five continents and nine countries, covering approximately 85% of…

1 week ago